首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination.
【24h】

HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination.

机译:流感疫苗接种后接受高活性抗逆转录病毒治疗的患者的HIV-1血浆病毒血症没有增加。

获取原文
获取原文并翻译 | 示例
       

摘要

The effect of vaccinating patients with sustained undetectable HIV-1 viremia (VL) achieved with highly active antiretroviral therapy was prospectively investigated. During the 1998 influenza immunization period, 39 HIV-1-infected patients who showed a VL<20 copies/ml for at least 6 months before the study entry date were vaccinated for influenza. Twenty-two vaccinees were immunized at entry. Seventeen controls were followed for 4 weeks after entry, crossing over then to the vaccination group. The proportion of patients with undetectable VL was not significantly different between the vaccination and control groups 2 and 4 weeks after entry. Therefore, influenza immunization of patients with undetectable viremia achieved with highly active antiretroviral therapy does not seem to affect VL.
机译:前瞻性地研究了通过高效抗逆转录病毒疗法为持续未检出的HIV-1病毒血症(VL)的患者接种疫苗的效果。在1998年流感疫苗免疫期间,对39名HIV-1感染患者进行了流感疫苗接种,这些患者在研究开始日期之前至少6个月内VL <20拷贝/毫升。进入时免疫了22种疫苗。入组后随访17个对照组,持续4周,然后过渡到疫苗接种组。接种后2周和4周,未检测到VL的患者比例在疫苗接种组和对照组之间没有显着差异。因此,用高效抗逆转录病毒疗法对未检测到病毒血症的患者进行流感免疫似乎不会影响VL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号